Translate Bio's Series B - II Round

Translate Bio raised a round of funding on July 30, 2015.

Translate Bio (NASDAQ: TBIO), formerly RaNA Therapeutics, is a biotechnology company committed to the development of next generation RNA-targeted medicines. The company's mission is to improve the liv…

Articles about Translate Bio's Series B - II Round: